Change takes time. Particularly in the life sciences, where a single drug’s journey from idea to market can consist of more than a decade of small, yet critical steps.
For New York, then, aspirations to become a region known for its... Read more »
Lessonly, the Indianapolis-based startup focused on team training software, this week announced it has raised an $8 million Series B funding round. Led by Boston’s OpenView Partners, the round also drew contributions from Rethink Education, High Alpha Capital... Read more »
Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear.
Sean Parker, Facebook’s first president, just joined a group that’s a favorite topic of history listicles: He’s an innovator who has become abashed by the breakthrough he helped to create.
[Updated 11/10/17, 10:25 a.m. See below.] Microsoft is applying the same model it used to launch its quantum computing and chatbot efforts to innovation in healthcare, signaling the company’s ambition and optimism about the transformative potential of artificial intelligence... Read more »
Raizlabs, one of the Boston area’s best-known mobile app development shops, has been acquired by Rightpoint, a Chicago-based consulting firm.
The purchase price wasn’t disclosed. With the addition of Raizlabs, the combined companies employ 400 people across nine U.S. offices. The... Read more »
The rising death toll from opioids has prompted policymakers to try various ways to take on the problem. President Trump’s opioid commission released its final report this week, calling for expansion of drug courts, better physician training, and penalties for insurers... Read more »
At Congressional hearings this week on Russia’s use of social media to interfere with the 2016 U.S. election, lawmakers pressed Facebook, Twitter, and Google to take exhaustive measures to stop the same thing from happening again.
Lawmakers urged the companies to... Read more »
After Techstars opened its first program in Boulder, CO, in 2007, the startup accelerator program expanded into three cities over the next four years. But then the real growth started happening. In 2011, Techstars began launching accelerators that focused on startups... Read more »
VP of Venture Capital, Pfizer Inc.
Dir., Alzheimer's Disease Research Inst., Cornell Medical College
Chair of Biochemistry and Molecular Biophysics, Columbia University
Professor of Molecular Biology, Rockefeller University
Senior Managing Partner, Aisling Capital Fund
Product Manager, Foursquare
CEO and Co-Founder of OnSwipe
Professor of Systems Biology, Columbia University
CEO of the New York Stem Cell Foundation
Partner, Avalon Ventures